南大光電(300346.SZ):擬購買美國杜邦集團的子公司名下新型硅前驅體系列的19項專利資產組
格隆匯 9 月 4日丨南大光電(300346.SZ)公佈,公司擬購買美國杜邦集團(英文全稱:DuPont de Nemours, Inc.)的全資子公司美國DDP特種電子材料公司(英文全稱:DDP Specialty Electronic Materials US 9, LLC,“DDP公司”)名下新型硅前驅體系列的19項專利資產組。購買價款包括一次性付款1000萬美元和商業化付款,即轉讓專利有效期間所有涵蓋產品淨銷售額的8.5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.